RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,879 | -57.4% | 46,651 | 0.0% | 0.00% | – |
| Q2 2023 | $51,316 | -6.7% | 46,651 | 0.0% | 0.00% | – |
| Q1 2023 | $55,000 | +66.7% | 46,651 | +92.3% | 0.00% | – |
| Q4 2022 | $33,000 | -44.1% | 24,255 | -33.3% | 0.00% | – |
| Q3 2022 | $59,000 | +168.2% | 36,358 | +29.6% | 0.00% | – |
| Q2 2022 | $22,000 | -56.0% | 28,054 | 0.0% | 0.00% | – |
| Q1 2022 | $50,000 | +6.4% | 28,054 | -13.1% | 0.00% | – |
| Q4 2021 | $47,000 | -28.8% | 32,280 | 0.0% | 0.00% | – |
| Q3 2021 | $66,000 | +37.5% | 32,280 | +52.2% | 0.00% | – |
| Q2 2021 | $48,000 | -23.8% | 21,207 | 0.0% | 0.00% | – |
| Q1 2021 | $63,000 | +37.0% | 21,207 | +30.0% | 0.00% | – |
| Q4 2020 | $46,000 | – | 16,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |